Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1451.391
- +9.284+0.64%
Caribou Biosciences Q4 2024 GAAP EPS $(0.39) Beats $(0.42) Estimate, Sales $2.08M Miss $2.11M Estimate
Beam Drops 9% on Phase 1/2 Data for Genetic Lung Disease Candidate
Beam Therapeutics Analyst Ratings
Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity
Beam Therapeutics Shares Are Trading Lower After the Company Announced a $500 Million Offering.
Agilent PD-L1 IHC 28-8 PharmDx Receives EU IVDR Certification As A Companion Diagnostic Test For Non-small Cell Lung Cancer And Melanoma Indications
Vertex Newly Approved Pain Treatment Lands Higher Cost Tier 3 Placement In UnitedHealth's Optum Rx Formularies
Live Stock News: Hard Week Reaching an End, AVGO Shows Semi's Are not Going Down Without a Fight
Tech Market Turmoil? Here’s Where Smart Investors Might be Looking
Vertex Pharma Drops as UnitedHealth Offers Tier 3 Coverage for New Pain Medicine
Cannabis For Pain Relief: Scientists Develop New Compound Without Mind-Altering Effects — Alternative To Opioids?
Retail Reports Rout, Chip Stocks Hurting with AVGO up Next: Live Stock News
Editas Medicine Q4 2024 GAAP EPS $(0.55) Misses $(0.38) Estimate, Sales $30.604M Miss $32.230M Estimate
Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst
Trump Halts Tariffs for Some Autos for One Month: Live Stock News
Earnings Scheduled For March 5, 2025
Live Stock News: -2.8% GDP, Trade War Sends Market Lower, Tesla Sales Punished
How Do Investors Really Feel About Agilent Technologies?
Ready Capital Stock Plummets After Q4 Results Dented by Write-downs, Multifamily Weakness
Live Stock News: Chips Falling Alongside Crypto Despite Trump Money News-- the Honeymoon is Over